An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma

MLA

Tao Han, et al. “An Immune Indicator Based on BTK and DPEP2 Identifies Hot and Cold Tumors and Clinical Treatment Outcomes in Lung Adenocarcinoma.” Scientific Reports, vol. 13, no. 1, Mar. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s41598-023-32276-2.

APA

Tao Han, Yafeng Liu, Jing Wu, Ying Bai, Jiawei Zhou, Chunxiao Hu, Wenting Zhang, Jianqiang Guo, Qingsen Wang, & Dong Hu. (2023). An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma. Scientific Reports, 13(1), 1–16. https://doi.org/10.1038/s41598-023-32276-2

Chicago

Tao Han, Yafeng Liu, Jing Wu, Ying Bai, Jiawei Zhou, Chunxiao Hu, Wenting Zhang, Jianqiang Guo, Qingsen Wang, and Dong Hu. 2023. “An Immune Indicator Based on BTK and DPEP2 Identifies Hot and Cold Tumors and Clinical Treatment Outcomes in Lung Adenocarcinoma.” Scientific Reports 13 (1): 1–16. doi:10.1038/s41598-023-32276-2.